An epidemic spread of multiresistant pseudomonas aeruginosa in a cystic fibrosis centre

Journal of Antimicrobial Chemotherapy

Volumn 17, Issue 4, 1986, Pages 505-516

  Pedersen, Svend Stenvang ^a   Koch, Christian ^a   Heiby, Niels ^a   Rosendal, Kirsten ^b  

^a Rigshospitalet   (Denmark)

^b Department of Hospital Infection ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZLOCILLIN; CARBENICILLIN; CEFOTAXIME; CEFSULODIN; CEFTAZIDIME; IMIPENEM; PIPERACILLIN; PROBENECID; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; CYSTIC FIBROSIS; DRUG SENSITIVITY; DRUG THERAPY; EPIDEMIOLOGY; HOSPITAL INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; THERAPY;

ADOLESCENT; ADULT; ANTIBIOTICS, LACTAM; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYSTIC FIBROSIS; DENMARK; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMAN; MALE; MICROBIAL SENSITIVITY TESTS; PATIENT ISOLATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN;

EID: 0022576641     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/17.4.505     Document Type: Article

References (45)

1. Asheshov, E. (1974). An assessment of the methods used for typing strains of Pseudomonas aeruginosa. Proceeding 6th Greek National Symposium on Microbiology, pp. 3-22. Athens.
2. Bou Casals, J. and Gylling Pedersen, O. (1972) Tablet sensitivity testing: A comparison of different methods. Acta Pathologica Microbiologica Scandinavica, Sect. 980, 806-816.
3. Bryan, L. E. (1978). Resistance to antimicrobial agents. The general nature of the problem and the basis of resistance. Pseudomonas aeruginosa. Clinical manifestation of infection and current therapy, pp. 219-70. Academic Press, New York.
4. Bryan L. E. (1984). Antimicrobial Drug resistance, p. 252. Academic press, Orlando.
5. Bryan, L. E., Kwan, S. and Godfrey, A. J. (1984). Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal β-lactamase to piperacillin, ceftazidime and cefsulodin. Antimicrobial Agents and Chemothererapy 25,382-384.
6. Cemy, F. J., Cropp, G. J. A. and Bye, M. R. (1984). Hospital therapy improves exercise tolerance and lung function in cystic fibrosis. American Journal of Diseases in Childhood 138,261-265.
7. Diem, K. and Lentner, C. (1968). Documenta Geigy. Wissenschaftliche Tabellen, pp36-39, 124-7. Gcigy, Basel.
8. Doggett, R. G. (1969). Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Journal of Applied Microbiology 18,936-937.
9. Doggett, R. G., Harrison, G. M., Stillwell, R. M. and Wallis, E. S. (1966). An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas. Journal of Pediatrics 68, 215-21.
10. Esterly, J. R. and Oppenheimer, E. H. (1968). Observations in cystic fibrosis of the pancreas. III. Pulmonary lesions. John Hopkins Medical Journal 122, 94-101.
11. Franco, J. A., Eitzman, D. V. and Baer, H. (1973). Antibiotic usage and microbial resistance in an intensive care nursery. American Journal of Diseases in Childhood 126, 318-321.
12. Godfrey, A. J. and Bryan, L. E. (1984). Resistance of Pseudomonas aeruginosa to new /Mactamase resistant /Mactarns. Antimicrobial Agents and Chemotherapy 26,485-488.
13. Goldstein, F. W., Gutman, L., Williamson, R., Collatz, E. and Acar, J. F. (1983). In vivo and in vitro emergence of simultaneous resistance to both β-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Aimaks Microbiologie 134A, 329-37.
14. Habs I. (1957). Untersuchungen uber die O-antigene von Pseudomonas aeruginosa. Zeitung fur Hygiene und Infektions Krankheiten 144,218-228.
15. Henry, R. L., Dorman, D. C., Brown, J. and Mellis C. (1982). Mucoid Pseudomonas aeruginosa in cystic fibrosis. Australian Pediatric Journal 18,43-45.
16. Heiby, N. (1977). Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Psedudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. (Diss). Acta Pathologica et Microbiologica Scandinavica, Sect C, Suppl. 226,3-96.
17. Heiby, N., Flensborg, E. W., Beck, B., Friis, B., Vidar Jacobsen, S. and Jacobsen, L. (1977). Pseudomonas aeruginosa infection in cystic fibrosis. Scandinavian Journal of Respiratory Diseases 58,65-79.
18. Heiby, N., Friis, B., Jensen, K., Koch, C., Meller, N. E., Stevring, S. and Szaflf, M. (1982). Antimicrobial chemotherapy in cystic fibrosis patients. Acta Paediatrica Scandinavica, Suppl. 301, 75-100.
19. Heiby, N. and Rosendal, K. (1980). Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre. Acta Pathologica et Microbiologica Scandinavica, Sect B 88, 125-131.
20. Heiby, N., Heilesen, A. and Meller, N. E. (1981). Development of Pseudomonas aeruginosa strains resistant to carbenicillin, azlodlhn, piperacillin and tobramycin during chemotherapy in cystic fibrosis patients. Monographics in Paediatrics 14,103-107.
21. Hoogkamp-Korstanje, J. A. A. and Laag, J. van der. (1980). Incidence and risk of cross-colonization in cystic fibrosis holiday camp. Anton Leeuwenhoek Journal of Microbiology 46,100-101.
22. Jessen, O. (1965). Pseudomonas aeruginosa and Other Green Fluorescent Pseudomonads (Diss), pp. 83-97. Munksgaard, Copenhagen.
23. Klinger, J. D. (1984). Cystic fibrosis: Horizons, p. 358. John Wiley, Chichester.
24. Kulczycki, L. L., Murphy, T. M. and Bellanti, J. A. (1978). Pseudomonas colonization in cystic fibrosis. A study of 160 patients. Journal of the American Medical Association 240,30-35.
25. Lautrop, H., Heiby, N., Bremmelgaard, A. and Korsager, B. (1979). Bakteriologiske undersegelsesmetoder, pp. 379-380. FADL’s forlag, Copenhagen.
26. Lowbury, E. J. L., Babb, J. R. and Rae, E. (1972). Clearance from a hospital of gram negative bacilli that transfer carbenicillin resistance to Pseudomonas aeruginosa. Lancet 1, 941-945.
27. Mikkelsen, O. S. (1968). Serotyping of Pseudomonas aeruginosa. 1. Studies on the production of anti O sera. Acta Pathologica Microbiologica Scandinavica 73,373-380.
28. Mikkelsen, O. S. (1970). Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification. Acta Pathologica Microbiologica Scandinavica, Sect. B 78, 163-175.
29. Meller, N. E. and Heiby, N. (1981). Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Scandinavian Journal of Infectious Diseases, Suppl. 21, 87-91.
30. Murray, S. A. and Snydman, D. R. (1982). Investigation of an epidemic of multi-drug resistant Pseudomonas aeruginosa. Infection Control 3, 456-460.
31. Neu, H. C. (1984). Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patients at risk for infection. American Journal of Medicine 76, 11-27.
32. Ojeniyi, B., Bsek, L. and Heiby, N. (1985). Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Acta Pathologica Microbiologica Scandinavica, Sect. B 93,7-13.
33. Permin, H., Koch, C., Heiby, N., Christensen, H. O., Friis-Meller, A. and Meller, S. (1983). Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis. Journal of Antimicrobial Chemotherapy 12 Suppl. A, 313-323.
34. Pier, G. B. (1985). Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. Journal of Infectious Diseases 151, 575-580.
35. Pollack, M. (1984). The virulence of Pseudomonas aeruginosa. Reviews of Infectious Diseases 6, S617-626.
36. Preheim, L. C., Penn, R. G., Sanders, C. C., Goering, R. V. and Giger, D. K. (1982). Emergence of resistance to /Mactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrobial Agents and Chemotherapy 22,1037-1041.
37. ressler, T., Szaff, M. and Haiby, N. (1984). Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzas infections in patients with cystic fibrosis. Acta Paediatrica Scandinavica 73, 541-547.
38. Reynolds, H. Y., di Sant’Agnese, P. A. and Zierdt, C. H. (1976). Mucoid Pseudomonas aeruginosa. A sign of cystic fibrosis in young adults with chronic pulmonary disease. Journal of the American Medical Association 236, 2190-2192.
39. Sanders, C. C. and Sanders Jr, E. (1983). Emergence of resistance during therapy with the newer β-lactam antibiotics role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 5,639-648.
40. Simpson, I. N., Plested, S. J., Budin-Jones, M. J., Lees, J., Hedges, R. W. and Jacoby, G. A. (1983). Characterisation of a novel plasmid-mediated β-lactamase and its contribution to β-lactam resistance in Pseudomonas aeruginosa. FEMS Microbiology Letters 19,23-27.
41. Szaff, M. and Haiby, N. (1982). Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis. Acta Paediatrica Scandinavica 71,821-826.
42. Szaff, M., Haiby, N. and Flensborg, E. W. (1983). Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatrica Scandinavica 72, 651-657.
43. Thomassen, M. J. and Root, J. M. (1980). Transmission of Pseudomonas aeruginosa among cystic fibrosis patients at summer camp. Proceeding 8th International Cystic Fibrosis Congress, Abstract 37. Toronto, Canada.
44. Wood, R. E., Boat, T. F. and Doershuk, C. F. (1976). State of the art: Cystic fibrosis. American Review of Respiratory Diseases 113,833-878.
45. Zimakoff, J., Haiby, N., Rosen dal, K. and Guilbert, J. P. (1983). Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. Journal of Hospital Infection 4, 31-40.